North Carolina · 86696

Analysis For Antibody To Herpes Simplex Virus, Type 2 in North Carolina

North Carolina Medicare Avg
$18.94
0% above national avg
National Medicare Avg
$18.93
All states combined
Billed Charge (NC)
$120.72
What providers submit
Est. Commercial (NC)
$41.28
National avg: $42.41
Est. Cash / Self-Pay (NC)
$47.40
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

3.2K
Services in NC
11
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in North Carolina

Provider Medicare Services
Laboratory Corporation Of America... $18.94 2.6K
Pathgroup Labs, Llc $18.93 505
Mako Medical Laboratories, Llc $18.96 68
Quest Diagnostics Clinical... $18.96 23
Laboratory Corporation Of America... $18.96 17

North Carolina Pricing in Context

In North Carolina, CPT code 86696 (Analysis For Antibody To Herpes Simplex Virus, Type 2) carries an average Medicare payment of $18.94 — 0% above the national benchmark of $18.93. 11 providers across the state submitted claims for this procedure in 2023, performing 3.2K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in North Carolina is $120.72, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in North Carolina lands near $41.28, with self-pay cash prices typically around $47.40. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Analysis For Antibody To Herpes Simplex Virus, Type 2 cost in North Carolina?

The average Medicare payment for Analysis For Antibody To Herpes Simplex Virus, Type 2 in North Carolina is $18.94, which is 0% above the national average of $18.93. Providers in NC typically bill $120.72 for this procedure.

What does Analysis For Antibody To Herpes Simplex Virus, Type 2 cost with insurance in North Carolina?

With commercial insurance in North Carolina, Analysis For Antibody To Herpes Simplex Virus, Type 2 costs an estimated $41.28. Without insurance, the estimated cash price is $47.40. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Analysis For Antibody To Herpes Simplex Virus, Type 2 in North Carolina?

11 providers in North Carolina billed Medicare for Analysis For Antibody To Herpes Simplex Virus, Type 2 in 2023, performing 3.2K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Analysis For Antibody To Herpes Simplex Virus, Type 2 cheaper in North Carolina than the national average?

No — Analysis For Antibody To Herpes Simplex Virus, Type 2 costs 0% above the national average in North Carolina. The state average Medicare payment is $18.94 compared to $18.93 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial